Premium
AN2 Therapeutics Inc (ANTX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NT... AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Show more
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.14 | 11.0236220472 | 1.27 | 1.45 | 1.26 | 222370 | 1.39920801 | CS |
| 4 | -0.21 | -12.962962963 | 1.62 | 1.6594 | 1.23 | 246465 | 1.44848354 | CS |
| 12 | 0.35 | 33.0188679245 | 1.06 | 1.675 | 0.975 | 533970 | 1.23865423 | CS |
| 26 | -0.74 | -34.4186046512 | 2.15 | 3.07 | 0.87 | 557229 | 1.23480481 | CS |
| 52 | -19.105 | -93.1269802583 | 20.515 | 22.22 | 0.87 | 437536 | 2.38796204 | CS |
| 156 | -15.44 | -91.6320474777 | 16.85 | 23.58 | 0.87 | 197783 | 4.47199434 | CS |
| 260 | -15.44 | -91.6320474777 | 16.85 | 23.58 | 0.87 | 197783 | 4.47199434 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
